ABIONYX (EPA:ABNX) | Finanzwire

Basculer en Français

9774	Companies
195575	Keywords
126557	Articles
103967	Press releases

Home
Companies
ABIONYX

BRIEF

published on 05/06/2025 at 21:38, 8 months 23 days ago

ABIONYX: Information on Voting Rights and Share Capital

Euronext Paris Share Capital Voting Rights Actions ABIONYX
PRESS RELEASE

published on 05/06/2025 at 21:33, 8 months 23 days ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025

Euronext Paris Shares Total Voting Rights ABIONYX Pharma April 30 2025
BRIEF

published on 03/21/2025 at 07:35, 10 months 8 days ago

CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Purchase Biopharma Innovative Treatments ABIONYX Pharma CIC Market Solutions
PRESS RELEASE

published on 03/21/2025 at 07:30, 10 months 8 days ago

Inside Information / Other news releases
CIC Market Solutions initiates buy coverage of ABIONYX Pharma. ABIONYX Pharma, a next-generation biopharma dedicated to innovative biomedicines based on recombinant apoA-I for severe inflammatory diseases, receives Buy recommendation from CIC Market Solutions

Buy Recommendation Biopharma ABIONYX Pharma CIC Market Solutions Innovative Biomedicines
BRIEF

published on 02/28/2025 at 07:35, 11 months 1 day ago

ABIONYX strengthens its commitment against LCAT Deficiency

Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE

published on 02/28/2025 at 07:30, 11 months 1 day ago

Inside Information / Other news releases
ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation

ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF

published on 02/27/2025 at 19:25, 11 months 2 days ago

ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024

2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
PRESS RELEASE

published on 02/27/2025 at 19:20, 11 months 2 days ago

Inside Information / Information on annual revenues
ABIONYX Pharma reports €4.6m revenue and €3.2m cash at the end of Q4 2024. Details on business activities and financial performance included

Revenue Cash Position Financial Update Biopharma ABIONYX Pharma
BRIEF

published on 02/20/2025 at 07:35, 11 months 9 days ago

ABIONYX Pharma receives €8.7 million in support for its sepsis project

Financial Support France 2030 ABIONYX Pharma Sepsis Biomedicine
BRIEF

published on 12/11/2024 at 12:16, 1 year 1 month ago

Threshold crossing by the CDC in ABIONYX PHARMA

Voting Rights CDC Threshold Crossing ABIONYX Pharma Bpifrance Participations

Accesswire

Published on 01/30/2026 at 02:15, 2 hours 56 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 5 hours 11 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 6 hours 11 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 10 hours 26 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 11 hours 11 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units

View all ACCESSWIRE

EQS Group

Published on 01/30/2026 at 04:30, 41 minutes ago

A First Look at AI in the Real World: AWE 2026 Opens This March in Shanghai
Published on 01/30/2026 at 03:35, 1 hour 36 minutes ago

Bybit Unveils 2026 Vision as "The New Financial Platform," Expanding Beyond Exchange Into Global Financial Infrastructure
Published on 01/30/2026 at 00:07, 5 hours 4 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appointment of independent non-executive director
Published on 01/29/2026 at 21:02, 8 hours 9 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 8 hours 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc

Les Echos

Published on 01/29/2026 at 18:00, 11 hours 11 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 11 hours 26 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 11 hours 26 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 11 hours 31 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 19 hours 4 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE